covidNZ.RdCase data published by the New Zealand Ministry of Health downloaded from the source on May 28, 2020.
The data consist of 1,154 individuals having been confirmed cases of COVID-19. Confirmed cases are people that have had a positive laboratory test.
A data frame with 1154 rows and 9 variables
The date notified of a potential case. This variable is of class "Date" in day-month-year format.
The sex of the person, a factor with two levels: Male and Female
The age group to which the person belongs. This is a factor having levels marked in year groups: "< 1", "01 to 04", "05 to 09", "10 to 14", "15 to 19", "20 to 29", "30 to 39", "40 to 49",
A character vector giving the name of the DHB or District Health Board where the case occurred.
A character vector indicating whether the patient recently travelled overseas.
A character vector giving the name, if known, of the last country visited by the person.
A character vector recording the number of the flight flown from the last country.
A vector of class "Date" giving the flight's departure date from the last country visited.
A vector of class "Date" giving the flight's arrival date from the last country visited.
New Zealand government health website accessed May 28, 2020.
From the source: (May 28, 2020: health.gov.nz) "The case definition has been amended to de-couple respiratory symptoms from a history of travel. Testing is available to people with respiratory symptoms suggestive of COVID-19 infection (including the acute onset of cough with or without fever). This is regardless of travel history or known contact with a confirmed or probable case of COVID-19. Priority groups for testing have been included in the case definitions."
"Confirmed case:
"A case that has laboratory definitive evidence. Laboratory definitive evidence requires at least one of the following: * detection of SARS-CoV-2 from a clinical specimen using a validated NAAT (PCR) * detection of coronavirus from a clinical specimen using pan-coronavirus NAAT (PCR) and confirmation as SARS-CoV-2 by sequencing * significant rise in IgG antibody level to SARS-CoV-2 between paired sera (when serological testing becomes available)."
R.W. Oldford